A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

BACKGROUND: The aim of this study is to demonstrate that capecitabine metronomic chemotherapy is non-inferior to capecitabine conventional chemotherapy as maintenance treatment, in patients who have responded to 16–18 weeks first-line chemotherapy in metastatic colorectal cancer (mCRC). METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Min, Ma, Tao, Xi, Wenqi, Jiang, Jinling, Wu, Junwei, Zhou, Chenfei, Yang, Chen, Zhu, Zhenggang, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059341/
https://www.ncbi.nlm.nih.gov/pubmed/32143730
http://dx.doi.org/10.1186/s13063-020-4194-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059341/
https://www.ncbi.nlm.nih.gov/pubmed/32143730
http://dx.doi.org/10.1186/s13063-020-4194-6

Ejemplares similares